Status:

COMPLETED

Partially Hydrolyzed Formula in Cow's Milk Protein Allergy After 6 Months of Elimination

Lead Sponsor:

Ain Shams University

Conditions:

Cow's Milk Protein Allergy

Eligibility:

All Genders

7-3 years

Phase:

NA

Brief Summary

For Patients diagnosed as cow milk protein allergy: Elimination of cow's milk products (CMPs) for 6 months. All infants were supplemented with Amino Acid-based Formula (AAF) (Neocate infant®/ Neocate...

Detailed Description

Phase Ⅰ:Initial assessment at enrollment i. Full medical history taking: with emphasis on: Personal History: Age- Sex- Order of birth- Consanguinity-Residence Main presenting symptoms: A- Gastrointe...

Eligibility Criteria

Inclusion

  • Artificially fed infants whether exclusively or complementary.
  • Confirmed diagnosis of CMPA based on clinical symptoms and signs and followed by withdrawal open re-challenge test

Exclusion

  • Exclusively breast-fed infants.
  • Anaphylactic type.
  • Multiple food Allergies.

Key Trial Info

Start Date :

January 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 28 2025

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06130085

Start Date

January 15 2024

End Date

March 28 2025

Last Update

May 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ain Shams University

Cairo, Egypt